|
|
|
|
Shire Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report
www.companiesandmarkets.com/Summary-Company-Profile/shire-plc-ph ..Shire Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure...
|
|
|
RF ablation reduces pain in bone cancer patients
ADHD AIDS Asthma Community Acquired MRSA Cardiovascular Diseases Cerebrovascular Diseases COPD Depression Diabetes Endocrine Diseases Geriatrics GI Disorders H1N1 Resources Headache High Cholesterol HPV Hypertension Insomnia Infection Managing Asthma Mental...
|
|
|
These 3 dermatologic disorders often have similar characteristics. Can you tell which is which?
ADHD AIDS Asthma Community Acquired MRSA Cardiovascular Diseases Cerebrovascular Diseases COPD Depression Diabetes Endocrine Diseases Geriatrics GI Disorders H1N1 Resources Headache High Cholesterol HPV Hypertension Insomnia Infection Managing Asthma Mental...
|
|
|
Articles Highlight Challenges, Progress in Nervous System Cancers
Newswise Many important clinical and basic scientific advances have been made in the past five years in the field of neuro-oncology, according to an editorial and several articles in the March issue of Archives of Neurology, one of the JAMA/Archives journals.
|
|
|
First Day on the Job as a Registered Nurse
The first day of starting my new job as a Registered Nurse was a lot like my first day of nursing school.I hardly slept the night before, could barely swallow my breakfast, and showed up nearly an hour early just because I was afraid I would be late. As it...
|
|
|
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
David Campbell, Ph.D., will Head Development of Drugs for Central Nervous System Disorders Carmine Stengone will Lead Business Development Efforts SAN DIEGO, March 8 /PRNewswire/ -- Afraxis, a San Diego-based biotechnology company developing drugs to...
|
|
|
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
David Campbell, Ph.D., will Head Development of Drugs for Central Nervous System Disorders Carmine Stengone will Lead Business Development Efforts SAN DIEGO, March 8 /PRNewswire/ -- Afraxis, a San Diego-based biotechnology company developing drugs to...
|
|
|
Saladax Biomedical Closes $8 Million Series C Financing
Let the jobs come to you!.announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of...
|
|
|
Saladax Biomedical Closes $8 Million Series C Financing
announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston.Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of Central Pennsylvania, as well as...
|
|
|
Saladax Biomedical Closes $8 Million Series C Financing
Saladax Biomedical, Inc.announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of...
|
|
|
Saladax Biomedical Closes $8 Million Series C Financing
Companies mentioned in this article: Saladax Biomedical, Inc.BETHLEHEM, Pa. -- (BUSINESS WIRE) -- Saladax Biomedical, Inc. announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants...
|
|
|
Saladax Biomedical announces closing of $8.4M Series C Preferred offering
Saladax Biomedical, Inc.announced today the close of an $8.4 million Series C Preferred offering led by Excel Venture Management of Boston. Participants included Golden Seeds LLC, Ben Franklin Technology Partners, and the Life Sciences Greenhouse of...
|
|
|
Fracture After Fall in a Middle-Aged African American Woman
ADHD AIDS Asthma Community Acquired MRSA Cardiovascular Diseases Cerebrovascular Diseases COPD Depression Diabetes Endocrine Diseases Geriatrics GI Disorders H1N1 Resources Headache High Cholesterol HPV Hypertension Insomnia Infection Managing Asthma Mental...
|
|
|
Enhance Your Dermatologic Prowess
ADHD AIDS Asthma Community Acquired MRSA Cardiovascular Diseases Cerebrovascular Diseases COPD Depression Diabetes Endocrine Diseases Geriatrics GI Disorders H1N1 Resources Headache High Cholesterol HPV Hypertension Insomnia Infection Managing Asthma Mental...
|
|
|
OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study
OmniComm Systems, Inc.(OTCBB: OMCM), a global provider of eClinical solutions, has been selected by an east coast biotechnology company as "vendor of choice" to perform electronic data capture (EDC) for an upcoming Phase II clinical study focusing on a...
|
|
|
Pyogenic Granuloma After Cryotherapy
ADHD AIDS Asthma Community Acquired MRSA Cardiovascular Diseases Cerebrovascular Diseases COPD Depression Diabetes Endocrine Diseases Geriatrics GI Disorders H1N1 Resources Headache High Cholesterol HPV Hypertension Insomnia Infection Managing Asthma Mental...
|
|
|
OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study
_ OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study.
|
|
|
Epileptic, organic and genetic vulnerabilities for timing of the development of interictal psychosis [PAPERS]
The British Journal of Psychiatry (2010) 196: 212-216.doi: 10.1192/bjp.bp.108.056721 2010 The Royal College of Psychiatrists This Article Submit an eLetter Citing Articles Google Scholar Epileptic, organic and genetic vulnerabilities for timing of the...
|
|
|
OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study
(MARKETWIRE via COMTEX) ----OmniComm Systems, Inc.(OTCBB: OMCM), a global provider of eClinical solutions, has been selected by an east coast biotechnology company as "vendor of choice" to perform electronic data capture (EDC) for an upcoming Phase II...
|
|
|
OmniComm Selected EDC 'Vendor of Choice' by Leading East Coast Based Biotech for Phase II Central Nervous Syst
FORT LAUDERDALE, FL -- (MARKET WIRE) -- 03/03/10 -- OmniComm Systems, Inc.(OTCBB: OMCM), a global provider of eClinical solutions, has been selected by an east coast biotechnology company as 'vendor of choice' to perform electronic data capture (EDC) for an...
|
|
|
OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study
_ OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study.
|
|
|
OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study
Companies mentioned in this article: OmniComm Systems, Inc.FORT LAUDERDALE, FL -- (Marketwire) -- 03/03/10 -- OmniComm Systems, Inc. (OTCBB: OMCM), a global provider of eClinical solutions, has been selected by an east coast biotechnology company as ...
|
|
|
OmniComm Selected EDC 'Vendor of Choice' by Leading East Coast Based Biotech for Phase II Central Nervous Syst
OmniComm Website Email a Friend Latest News Releases SOURCE: OmniComm Systems, Inc.FORT LAUDERDALE, FL--(Marketwire - March 3, 2010) - OmniComm Systems, Inc. (OTCBB 'OmniComm is pleased to have been selected to provide EDC for another prestigious client,'...
|
|
|
OmniComm Selected EDC "Vendor of Choice" by Leading East Coast Based Biotech for Phase II Central Nervous System Study
FORT LAUDERDALE, FL -- (MARKET WIRE) -- 03/03/10 -- OmniComm Systems, Inc.(OTCBB: OMCM), a global provider of eClinical solutions, has been selected by an east coast biotechnology company as "vendor of choice" to perform electronic data capture (EDC) for an...
|
|
|
OmniComm Selected EDC 'Vendor of Choice' by Leading East Coast Based Biotech for Phase II Central Nervous Syst
'OmniComm is pleased to have been selected to provide EDC for another prestigious client,' said Stephen Johnson, COO of OmniComm Systems.'We continue to work toward maintaining our reputation for service and support, and providing EDC solutions proven to...
|
